P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL

Bibliographic Details
Main Authors: Thomas D. Coates, Maria Domenica Cappellini, Sujit Sheth, Kevin H.M. Kuo, Antonio Giulio Piga, Antonis Kattamis, Martina Perin, Frederik Lersch, Jeevan K. Shetty, Yinzhi Lai, Wen-Ling Kuo, Ali T. Taher
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000972748.88204.9a
_version_ 1797279979423137792
author Thomas D. Coates
Maria Domenica Cappellini
Sujit Sheth
Kevin H.M. Kuo
Antonio Giulio Piga
Antonis Kattamis
Martina Perin
Frederik Lersch
Jeevan K. Shetty
Yinzhi Lai
Wen-Ling Kuo
Ali T. Taher
author_facet Thomas D. Coates
Maria Domenica Cappellini
Sujit Sheth
Kevin H.M. Kuo
Antonio Giulio Piga
Antonis Kattamis
Martina Perin
Frederik Lersch
Jeevan K. Shetty
Yinzhi Lai
Wen-Ling Kuo
Ali T. Taher
author_sort Thomas D. Coates
collection DOAJ
first_indexed 2024-03-07T16:34:37Z
format Article
id doaj.art-8efb778ff67647b0a10b1b13d0f8fc95
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T16:34:37Z
publishDate 2023-08-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-8efb778ff67647b0a10b1b13d0f8fc952024-03-03T10:04:27ZengWileyHemaSphere2572-92412023-08-017e882049a10.1097/01.HS9.0000972748.88204.9a202308003-01361P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIALThomas D. Coates0Maria Domenica Cappellini1Sujit Sheth2Kevin H.M. Kuo3Antonio Giulio Piga4Antonis Kattamis5Martina Perin6Frederik Lersch7Jeevan K. Shetty8Yinzhi Lai9Wen-Ling Kuo10Ali T. Taher111 Children’s Hospital Los Angeles, Children’s Center for Cancer and Blood Diseases, Los Angeles, CA, United States3 Fondazione IRCCS Ca’ Granda Policlinico Hospital, University of Milan, Milan, Italy4 Weill Cornell Medicine, Division of Pediatric Hematology/Oncology, New York, NY, United States5 University Health Network, Division of Medical Oncology and Hematology, Department of Medicine, Toronto, ON, Canada7 University of Turin, Turin, Italy8 National and Kapodistrian University of Athens, First Department of Pediatrics, Athens, Greece9 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland9 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland9 Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland10 Bristol Myers Squibb, Princeton, NJ, United States10 Bristol Myers Squibb, Princeton, NJ, United States11 American University of Beirut Medical Center, Department of Internal Medicine, Beirut, Lebanonhttp://journals.lww.com/10.1097/01.HS9.0000972748.88204.9a
spellingShingle Thomas D. Coates
Maria Domenica Cappellini
Sujit Sheth
Kevin H.M. Kuo
Antonio Giulio Piga
Antonis Kattamis
Martina Perin
Frederik Lersch
Jeevan K. Shetty
Yinzhi Lai
Wen-Ling Kuo
Ali T. Taher
P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
HemaSphere
title P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
title_full P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
title_fullStr P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
title_full_unstemmed P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
title_short P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIAL
title_sort p1466 effect of luspatercept on bone mineral density in patients with beta thalassemia enrolled in the phase 3 believe trial
url http://journals.lww.com/10.1097/01.HS9.0000972748.88204.9a
work_keys_str_mv AT thomasdcoates p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT mariadomenicacappellini p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT sujitsheth p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT kevinhmkuo p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT antoniogiuliopiga p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT antoniskattamis p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT martinaperin p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT frederiklersch p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT jeevankshetty p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT yinzhilai p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT wenlingkuo p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial
AT alittaher p1466effectofluspaterceptonbonemineraldensityinpatientswithbetathalassemiaenrolledinthephase3believetrial